OBJECTIVE: To assess double reading effectiveness in mammography screening. DESIGN: Retrospective study of 177,631 consecutive mammograms double read during 1998-2003. SETTING: The Florence screening programme, involving 11 trained radiologists. Abnormalities reported by at least one reader prompted assessment. RESULTS: The referral rate was 2.89% for the first reader, 3.15% for the second reader, and 3.59% for either reader. Of 713 total cancers detected, 43 were suspected only by the second reader (6.4% relative, 0.024% increase in absolute detection rate) and had a lower stage compared to the first reader (pTis-pT1b = 65.7 versus 52.0%): 41 were reviewed and classified (error type) as "minimal sign" in six, and "screening error" in 35 cases, or as BI-RADS 3 in one, 4a in 20, 4b in 13, and 4c in three cases. The second reading cost was 2.70 per woman examined, or 11,168 per additional cancer detected (versus 11,585 at a single reading). DISCUSSION: Second reading is effective in detecting a limited number of additional cancer cases. Tumour stage (one-third over 1 cm in diameter) and review findings (high rate of "screening errors" and BI-RADS R4b-c categories) suggest that second reading detects small "difficult cases" as well as larger cancers missed due to fatigue or loss of attention. Second reading reduces screening specificity to a minor extent, and since cancer detection at second reading seems cost-effective the procedure is recommendable in routine practice.
OBJECTIVE: To assess double reading effectiveness in mammography screening. DESIGN: Retrospective study of 177,631 consecutive mammograms double read during 1998-2003. SETTING: The Florence screening programme, involving 11 trained radiologists. Abnormalities reported by at least one reader prompted assessment. RESULTS: The referral rate was 2.89% for the first reader, 3.15% for the second reader, and 3.59% for either reader. Of 713 total cancers detected, 43 were suspected only by the second reader (6.4% relative, 0.024% increase in absolute detection rate) and had a lower stage compared to the first reader (pTis-pT1b = 65.7 versus 52.0%): 41 were reviewed and classified (error type) as "minimal sign" in six, and "screening error" in 35 cases, or as BI-RADS 3 in one, 4a in 20, 4b in 13, and 4c in three cases. The second reading cost was 2.70 per woman examined, or 11,168 per additional cancer detected (versus 11,585 at a single reading). DISCUSSION: Second reading is effective in detecting a limited number of additional cancer cases. Tumour stage (one-third over 1 cm in diameter) and review findings (high rate of "screening errors" and BI-RADS R4b-c categories) suggest that second reading detects small "difficult cases" as well as larger cancers missed due to fatigue or loss of attention. Second reading reduces screening specificity to a minor extent, and since cancer detection at second reading seems cost-effective the procedure is recommendable in routine practice.
Authors: Elisabeth G Klompenhouwer; Adri C Voogd; Gerard J den Heeten; Luc J A Strobbe; Vivianne C Tjan-Heijnen; Mireille J M Broeders; Lucien E M Duijm Journal: Eur Radiol Date: 2015-04-18 Impact factor: 5.315
Authors: Patrick C Brennan; Aarthi Ganesan; Miguel P Eckstein; Ernest Usang Ekpo; Kriscia Tapia; Claudia Mello-Thoms; Sarah Lewis; Mordechai Z Juni Journal: Acad Radiol Date: 2018-07-29 Impact factor: 3.173
Authors: Jules H Sumkin; Marie A Ganott; Denise M Chough; Victor J Catullo; Margarita L Zuley; Dilip D Shinde; Christiane M Hakim; Andriy I Bandos; David Gur Journal: Acad Radiol Date: 2015-09-26 Impact factor: 3.173
Authors: M Pellegrini; D Bernardi; S Di Michele; P Tuttobene; C Fantò; M Valentini; P Peterlongo; F Caumo; A Frigerio; S Ciatto Journal: Radiol Med Date: 2011-07-09 Impact factor: 3.469
Authors: R Chersevani; S Ciatto; C Del Favero; A Frigerio; L Giordano; G Giuseppetti; C Naldoni; P Panizza; M Petrella; G Saguatti Journal: Radiol Med Date: 2010-01-15 Impact factor: 3.469
Authors: Michael S Hofman; Nigel C Smeeton; Sheila C Rankin; Tom Nunan; Michael J O'Doherty Journal: Eur J Nucl Med Mol Imaging Date: 2008-10-01 Impact factor: 9.236